Compare Stocks: GRAB, TDUP, and VXRT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GRAB Grab	$3.01 -1.0%	$3.59	$2.96 ▼ $6.62	$12.33B	0.89	49.35 million shs	85.76 million shs
TDUP ThredUp	$2.60 -3.7%	$4.60	$2.48 ▼ $11.16	$341.46M	1.97	2.36 million shs	1.88 million shs
VXRT Vaxart	$0.49 -0.3%	$0.53	$0.31 ▼ $0.84	$118.46M	1.06	518,991 shs	198,347 shs

10 Best Stocks to Own - Fall 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GRAB Grab	-6.46%	-13.88%	-17.17%	-9.25%	-42.53%
TDUP ThredUp	+1.12%	-0.37%	-16.41%	-45.56%	-74.84%
VXRT Vaxart	-3.71%	-1.12%	-15.65%	-14.70%	+27.63%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GRAB Grab	$3.01 -1.0%	$3.59	$2.96 ▼ $6.62	$12.33B	0.89	49.35 million shs	85.76 million shs
TDUP ThredUp	$2.60 -3.7%	$4.60	$2.48 ▼ $11.16	$341.46M	1.97	2.36 million shs	1.88 million shs
VXRT Vaxart	$0.49 -0.3%	$0.53	$0.31 ▼ $0.84	$118.46M	1.06	518,991 shs	198,347 shs

10 Best Stocks to Own - Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GRAB Grab	-6.46%	-13.88%	-17.17%	-9.25%	-42.53%
TDUP ThredUp	+1.12%	-0.37%	-16.41%	-45.56%	-74.84%
VXRT Vaxart	-3.71%	-1.12%	-15.65%	-14.70%	+27.63%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GRAB Grab	2.82	Moderate Buy	$6.01	99.52% Upside
TDUP ThredUp	2.60	Moderate Buy	$6.55	151.92% Upside
VXRT Vaxart	2.00	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest GRAB, TDUP, and VXRT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/17/2026	GRAB Grab	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
8/6/2026	TDUP ThredUp	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$6.50
8/6/2026	TDUP ThredUp	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$7.00 ➝ $6.00
8/4/2026	GRAB Grab	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/3/2026	GRAB Grab	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C-)
7/9/2026	GRAB Grab	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$7.00 ➝ $5.00
7/9/2026	VXRT Vaxart	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
6/30/2026	GRAB Grab	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$6.25
6/24/2026	TDUP ThredUp	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 9/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GRAB Grab	$3.37B	3.66	$0.10 per share	29.93	$1.65 per share	1.82
TDUP ThredUp	$310.81M	1.10	N/A	N/A	$0.47 per share	5.53
VXRT Vaxart	$237.26M	0.50	$0.10 per share	4.92	$0.37 per share	1.32

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GRAB Grab	$268M	$0.06	50.18	23.15	0.85	15.97%	8.83%	4.92%	11/3/2026 (Estimated)
TDUP ThredUp	-$20.21M	-$0.17	N/A	N/A	N/A	-6.65%	-37.30%	-13.03%	11/2/2026 (Estimated)
VXRT Vaxart	$16.33M	$0.16	3.04	N/A	N/A	15.88%	53.04%	20.85%	11/12/2026 (Estimated)

Latest GRAB, TDUP, and VXRT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	VXRT Vaxart	-$0.12	-$0.06	+$0.06	-$0.06	$26.21 million	$27.19 million
8/5/2026	Q2 2026	TDUP ThredUp	-$0.0298	-$0.05	-$0.0202	-$0.05	$90.34 million	$90.77 million
8/4/2026	Q2 2026	GRAB Grab	$0.0495	$0.06	+$0.0105	$0.06	$994.97 million	$997.00 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
GRAB Grab	N/A	N/A	N/A	N/A	N/A
TDUP ThredUp	N/A	N/A	N/A	N/A	N/A
VXRT Vaxart	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GRAB Grab	0.06	1.52	1.51
TDUP ThredUp	0.29	0.99	0.99
VXRT Vaxart	N/A	1.60	1.60

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GRAB Grab	55.52%
TDUP ThredUp	89.08%
VXRT Vaxart	18.05%

Insider Ownership

Company	Insider Ownership
GRAB Grab	3.60%
TDUP ThredUp	23.10%
VXRT Vaxart	2.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GRAB Grab	12,012	4.10 billion	3.95 billion	Optionable
TDUP ThredUp	2,132	131.33 million	101.00 million	Optionable
VXRT Vaxart	120	243.20 million	236.39 million	No Data

GRAB, TDUP, and VXRT Headlines

Recent News About These Companies

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 8 at 10:01 AM | finance.yahoo.com

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 8 at 8:00 AM | globenewswire.com

Vaxart Secures New European Patent Covering Oral Norovirus Vaccine Technology

August 27, 2026 | finance.yahoo.com

Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology

August 26, 2026 | globenewswire.com

Vaxart (OTCMKTS:VXRT) Share Price Passes Below 200 Day Moving Average - Here's Why

August 26, 2026 | marketbeat.com

Vaxart (OTCMKTS:VXRT) Stock Crosses Below Two Hundred Day Moving Average - Should You Sell?

August 18, 2026 | marketbeat.com

Vaxart Inc (VXRT) (Q2 2026) Earnings Call Highlights: Oral COVID Vaccine Shows Promise, Cash ...

August 10, 2026 | finance.yahoo.com

Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding

August 8, 2026 | seekingalpha.com

Vaxart, Inc. (VXRT) Q2 2026 Earnings Call Transcript

August 7, 2026 | seekingalpha.com

Vaxart Provides Business Update and Reports Second Quarter 2026 Financial Results

August 6, 2026 | markets.businessinsider.com

Vaxart Q2 2026 earnings preview

August 5, 2026 | msn.com

Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET

July 30, 2026 | finance.yahoo.com

Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET

July 30, 2026 | globenewswire.com

Vaxart to Participate in BTIG Biotechnology Conference 2026

July 21, 2026 | finance.yahoo.com

Vaxart to Participate in BTIG Biotechnology Conference 2026

July 21, 2026 | globenewswire.com

Vaxart Announces Results of Annual Meeting of Stockholders

July 17, 2026 | finance.yahoo.com

Vaxart Announces Results of Annual Meeting of Stockholders

July 17, 2026 | globenewswire.com

Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine

July 6, 2026 | finance.yahoo.com

Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine

July 6, 2026 | globenewswire.com

Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements

July 1, 2026 | finance.yahoo.com

Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements

July 1, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRAB, TDUP, and VXRT Company Descriptions

Grab NASDAQ:GRAB

$3.01 -0.03 (-0.99%)

Closing price 04:00 PM Eastern

Extended Trading

$3.02 +0.02 (+0.50%)

As of 06:23 PM Eastern

Grab Holdings Limited engages in the provision of superapps in Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam. The company offers its Grab ecosystem, a single platform with superapps for driver- and merchant-partners and consumers, that allows access to mobility, delivery, digital financial services, and enterprise sector offerings. Grab Holdings Limited is headquartered in Singapore.

ThredUp NASDAQ:TDUP

$2.60 -0.10 (-3.70%)

Closing price 04:00 PM Eastern

Extended Trading

$2.60 +0.00 (+0.19%)

As of 06:04 PM Eastern

ThredUp Inc., together with its subsidiaries, operates an online resale platform in the United States and internationally. Its platform enables consumers to buy and sell primarily secondhand apparel, shoes, and accessories. ThredUp Inc. was incorporated in 2009 and is headquartered in Oakland, California.

Vaxart OTCMKTS:VXRT

$0.49 0.00 (-0.27%)

As of 03:58 PM Eastern

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GRAB, TDUP, and VXRT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GRAB, TDUP, and VXRT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GRAB, TDUP, and VXRT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRAB, TDUP, and VXRT Company Descriptions

Grab NASDAQ:GRAB

ThredUp NASDAQ:TDUP

Vaxart OTCMKTS:VXRT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GRAB, TDUP, and VXRT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GRAB, TDUP, and VXRT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GRAB, TDUP, and VXRT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRAB, TDUP, and VXRT Company Descriptions

Grab NASDAQ:GRAB

ThredUp NASDAQ:TDUP

Vaxart OTCMKTS:VXRT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools